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ABSTRACT 
 
Objective: To investigate the difference between the risk of stroke according to 
blood pressure level in people with and without proteinuria. 
Methods: Blood pressure, urine protein, and other cardiovascular risk factors 
were measured in 102,672 Korean men and 60,443 Korean women aged 35 to 59 
years in 1990 and 1992. Blood pressure level was classified as non-hypertensive, 
stage 1 and stage 2 hypertension, and it was based on JNC-7 classification. 
Proteinuria positive was defined as a dipstick finding of 1+ or greater in either of 
the 1990 and the 1992 examinations. The principal outcome variables were 
morbidity and mortality from (1) intracerebral hemorrhage (International 
Classification of Disease 10th revision [ICD-10] codes I61); (2) subarachnoid 
hemorrhage (ICD-10 codes I60); and (3) ischemic stroke (ICD-10 codes I63, I65 
and I66) in an 11 year follow-up from 1993 to 2003. 
Results: In baseline examination, proteinuria positive was detected in 1,813 
(1.77%) men. 22,179 (21.60%) men had stage 1 hypertension and 6,459 (6.29%) 
men had stage 2 hypertension. During the follow-up period, there were 554 cases 
of intracerebral hemorrhage, 152 cases of subarachnoid hemorrhage, and 1978 
cases of ischemic stroke. In men, the multivariate-adjusted relative risks (95% 
confidence interval) of proteinuria positive was 2.60 (1.71-3.94) for intracerebral 
hemorrhage, 0.44 (0.06-3.21) for subarachnoid hemorrhage and 1.16 (0.89-1.52) 
for ischemic stroke. The relative risks of stage 2 hypertension were 4.20 (3.15-
5.61) for intracerebral hemorrhage, 1.60 (0.98-2.45) for subarachnoid 
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hemorrhage and 1.26 (1.10-1.46) for ischemic stroke. In men with proteinuria 
negative, the relative risks of stage 2 hypertension were 1.54 (0.90-2.65) for 
intracerebral hemorrhage, 0.96 (0.33-2.75) for subarachnoid hemorrhage, and 
0.86 (0.66-1.11) for ischemic stroke. In men with proteinuria positive, the 
relative risks of stage 2 hypertension were 45.03 (3.85-526.41) for intracerebral 
hemorrhage, 0.96 (0.33-2.75) for subarachnoid hemorrhage, and 0.39 (0.11-1.40) 
for ischemic stroke. The systolic blood pressure with the largest area under curve 
(AUC) value of receiver operating characteristic (ROC) analysis to predict 
intracerebral hemorrhage was 140 mmHg in men with proteinuria negative and 
135mmHg in men with proteinuria positive. 
Conclusion: In men with proteinuria, the risk of hypertension for intracerebral 
hemorrhage significantly increased, compared to the risk of hypertension for 
intracerebral hemorrhage in men without proteinuria. From the results of this 
study, it could be suggested that early screening and appropriate management of 
both hypertension and proteinuria can be helpful to prevent intracerebral 
hemorrhage. 
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1. INTRODUCTION 
 
Hypertension is considered the strongest risk factor for stroke. Therefore, 
management of blood pressure under a certain level is important in preventing 
strokes. (Cosentino et al, 2005; Song et al, 2004) 
There have been studies that reported the increased risk of stroke in people 
with proteinuria. (McCullough  et al, 2007; Madison et al, 2006; Kasper et al, 
2005; Tanihara et al, 2005; Yuyun et al, 2004; Roest et al, 2001; Makino et al, 
2000; Beamer et al, 1999; Guerrero-Romero et al, 1999; Lin et al, 1984) 
Therefore, blood pressure control for people with proteinria is known as 
important to prevent stroke. The JNC-7 report recommended special 
considerations, a strict blood pressure target of 130/80 mmHg for people with 
diabetes or chronic kidney disease patients. This target is lower than the 140/90 
mmHg target in other situations. (Chobanian et al, 2003) 
There are some studies that investigated the combined effect of multiple risk 
factors (blood pressure, total cholesterol, blood glucose level) on the risk of 
cardiovascular disease. However, few studies have investigated how blood 
pressure level affects the risk of stroke in people by the presence of proteinuria. 
Most studies on the association between proteinuria and the risk of stroke were 
performed in western countries and focused on ischemic stroke. (Madison et al, 
2006; Yuyun et al, 2004; Roest et al, 2001; Beamer et al, 1999; Guerrero-
Romero et al, 1999) Studies in Japan reported the inconsistent risk of proteinuria 
and stroke subtype. (Makino et al, 2000, Lin et al, 1984, Kagan et al, 1985) 
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These studies did not show comparison of risks among stroke subtypes because 
of short follow-up periods and insufficient cases in each stroke subtype. 
This study investigated the difference between the risk of stroke according 
to blood pressure level in people with and without proteinuria in a cohort of 11 
years of follow-up.
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2. OBJECTIVE 
 
To investigate the difference between the risk of stroke according to blood 
pressure level in people with and without proteinuria in a cohort of 11 years of 
follow-up. 
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3. METHODS 
 
Study Population 
 
The Korea Medical Insurance Corporation (KMIC) study is a cohort study 
of 172,584 people that is designed to assess the risk factors for chronic diseases. 
Of the entire South Korean population, which was approximately 43 million in 
1990, 4,603,361 (10.7 %) were insured by KMIC, including 1,213,594 workers 
and their 3,389,767 dependents. KMIC covered civil servants, private teachers, 
and their dependents. All insured workers were required to participate in biennial 
medical examinations performed by KMIC. In 1990 and 1992, 94.5 % and 
94.4 %, respectively, completed biennial examinations. The cohort in the KMIC 
study is a systematic, random sample of 108,464 men and 64,120 women, aged 
35-59 years. 
Of the 172,584 persons, 9,469 (5.5 %) persons were excluded because of 
incomplete data at baseline for proteinuria, systolic blood pressure, diastolic 
blood pressure or any of the cardiovascular risk factors studied (serum 
cholesterol concentration, fasting blood glucose concentration, body mass index, 
and smoking status), or people that reported one or more previously diagnosed 
diseases. This resulted in a final sample size of 163,115 persons: 102,672 men 
and 60,443 women. 
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Data Collection 
 
Baseline information was obtained from health examinations in 1990 and 
1992. Averages of the two measurements taken during these examinations were 
used. The examinations were conducted in a standardized manner by trained 
medical staff at 416 hospitals nationwide. 
The participants’ weight, height, and blood pressure were measured at each 
examination. Fasting blood specimens were analyzed by automated instruments 
at each hospital for total cholesterol, glucose, and hemoglobin concentration. 
Fasting blood specimens were analyzed by automated instruments at each 
hospital for total cholesterol, glucose, and hemoglobin concentration. Each 
hospital that participated in the health assessment followed the internal and 
external quality control procedures stipulated by the Korean Society of Quality 
Control in Clinical Pathology. (Min et al, 2001) 
Systolic and diastolic blood pressure was measured in the seated position 
with a mercury sphygmomanometer or automatic manometer. They were divided 
into three groups of blood pressure level; non-hypertensive (systolic blood 
pressure < 140mmHg and diastolic blood pressure < 90mmHg); stage 1 
hypertension (140 to 159/90 to 99 mm Hg); stage 2 hypertension (>=160/>=100 
mm Hg). When systolic and diastolic blood pressures fell into different 
categories, the higher category was selected. (Chobanian et al, 2003) 
Urine protein concentration was determined by a urine dipstick semi-
quantitative analysis (N-multistix; Ames Division of Miles Laboratory Inc, 
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Elkhart, Ind). The results of the urine test were based on a color scale that 
quantified proteinuria as absent, trace, 1+, 2+, 3+, and 4+. Dipstick results of 
trace, 1+, and 2+ corresponded to protein concentrations of about 0.1, 0.3, and 
1.0 g/L, respectively. Reported specificity was 97.4  % and sensitivity was 
46.0 %. (Atkins et al, 2003 Pugia et al, 2001) Proteinuria status was defined as 
positive (with proteinuria) or negative (without proteinuria); proteinuria positive 
was defined as dipstick finding of 1+ or greater in either of the 1990 and 1992 
examinations. 
The principal outcome variables were morbidity and mortality from (1) 
intracerebral hemorrhage (International Classification of Disease 10th revision 
[ICD-10] codes I61); (2) subarachnoid hemorrhage (ICD-10 codes I60); and (3) 
ischemic stroke (ICD-10 codes I63, I65 and I66). The follow-up period was 11 
years, from 1993 to 2003. For individuals who had more than one event, only the 
first event was used in analyses. Non-fatal outcomes were ascertained from 
health insurance claim data and fatal outcomes from death certification data. 
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Statistical Analysis 
 
Men and women were studied separately. The categories for fasting glucose 
concentrations was < 100.0, 100.0 to 126.0, and ≥126.0 mg/dL. The categories 
for serum cholesterol concentrations were <200.0, 200.0 to 240.0, and ≥240.0 
mg/dL. Smoking status categories included current smokers, ex-smokers, and 
nonsmokers. Based on the average daily alcohol intake, participants were 
classified as non-drinkers, moderate drinkers (<50g/d), or heavy drinkers 
(>=50g/d). In respective proteinuria status, subjects were divided into blood 
pressure level: non-hypertensive, stage 1 and stage 2 hypertension. 
To calculate relative risk, Cox’s proportional-hazards models were used in 
each subgroup of blood pressure level and proteinuria after adjustment for the 
aforementioned variables. For all relative risks, 95 % confidence intervals were 
calculated. 
To evaluate predictability for stroke in subjects with specific blood pressure 
level in respective proteinuria status, receiver operating characteristic (ROC) 
analysis was performed. The results of ROC analysis described sensitivity, 
specificity, and area under curve (AUC). The AUC on specific systolic blood 
pressure level, which was adjusted for variables used in calculating relative risk, 
is considered to be a cut-off value for detecting strokes. 
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4. RESULTS 
 
Baseline Characteristics of the Study Population 
 
Table 1 shows the baseline characteristics of the study population. The mean 
age was 44.92 years old for men and 42.42 years old for women. Proportions of 
hypertension were 27.89 % in men and 10.46 % in women. Proteinuria positive 
was detected in 1,813 men (1.77 %) and 600 women (0.99 %). 
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Table 1. Baseline Characteristics of Study Population 
Data is presented as mean ± SD or No.( %). 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination. 
 
Men Women Characteristic 
N=102,672 N=60,443 
Age, years 44.92 ± 6.66 42.42 ± 6.67 
Body mass index, Kg/m2 23.47 ± 2.40 23.32 ± 2.48 
Total serum cholesterol, mg/dL 194.25 ± 32.95 189.37 ± 32.45 
Fasting serum glucose, mg/dL 92.30 ± 18.37 86.09 ± 11.70 
Blood pressure level      
Non-hypertensive 74,034 (72.11) 54,120 (89.54) 
Stage 1 hypertension 22,179 (21.60) 5,061 (8.37) 
Stage 2 hypertension  6,459 (6.29) 1,262 (2.09) 
Proteinuria status     
Negative 100,859 (98.23) 59,843 (99.01) 
Positive* 1,813 (1.77) 600 (0.99) 
Alcohol intake, g/day     
<50 93,196 (90.77) 59,304 (98.12) 
≥50 9,476 (9.23) 1,139 (1.88) 
Smoking status     
Non-smoker 20,973 (21.30) 49,017 (99.15) 
Ex-smoker 20,365 (20.68) 220 (0.45) 
Current smoker 57,133 (58.02) 198 (0.40) 
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Baseline Characteristics of the Study Population according to Blood 
Pressure Level in Respective Proteinuria Status 
 
Table 2 shows the baseline characteristics of the study population according 
to blood pressure level in respective proteinuria status. Body mass index, total 
serum cholesterol, and fasting serum glucose level increased from the left to the 
right of the table. (p-value for trend <0.001). 
At the same level of blood pressure, these values were higher in men and 
women with proteinuria positive. The proportion of subjects who drank more 
than 50g alcohol a day and current smokers did not show this trend.
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Table 2. Baseline Characteristics according to Blood Pressure Level in Respective Proteinuria Status 
 Proteinuria negative  Proteinuria positive* Characteristics 
 Non-
hypertensive 
Stage1 
hypertension 
Stage2 
hypertension 
 
 
Non-
hypertensive 
Stage1 
hypertension 
Stage2 
Hypertension 
p-value 
for 
trend 
Men, N=102,672  N=73,132 N=21,615 N=6,112  N=902 N=564 N=347  
Age, years  44.04± 6.50 46.75± 6.63 48.63± 6.14  44.97± 6.54 46.87± 6.39 47.93± 5.94 <0.001 
Body mass index, Kg/m2  23.17± 2.32 24.11± 2.40 24.44± 2.49  23.78± 2.62 24.77± 2.64 25.24± 2.88 <0.001 
Total serum cholesterol, mg/dL  191.73±31.80 199.26±34.04 202.26±35.88  203.79±38.33 206.85±39.18 212.99±45.90 <0.001 
Fasting serum glucose, mg/dL  90.66±16.32 95.36±20.75 98.31±23.55  96.19±27.77 102.75±29.73 105.28±32.23 <0.001 
% of alcohol drinker ≥50g/day  6,236 (8.53) 2,287 (10.58) 739 (12.09)  89  (9.87) 82 (14.54) 43 (12.39) <0.001 
% of current smokers  41,794 (59.52) 11,371 (54.83) 2,999 (51.79)  512 (60.09) 288 (53.73) 169 (50.75) <0.001 
Women, N=60,443  N=53,666 N=4970 N=1207  N=454 N=91 N=55  
Age, years  41.83± 5.88 47.05± 6.49 49.41± 5.85  42.35± 5.74 46.21± 6.30 47.16± 6.26 <0.001 
Body mass index, Kg/m2  22.12± 2.37 23.81± 2.71 24.55± 2.86  22.57± 2.85 24.52± 2.94 24.77± 3.65 <0.001 
Total serum cholesterol, mg/dL  187.57±31.60 203.23±34.89 208.69±36.43  191.69±33.30 209.71±41.91 216.69±43.80 <0.001 
Fasting serum glucose, mg/dL  85.52±10.78 89.90±14.45 93.42±20.28  88.74±20.99 95.93±28.27 98.96±30.67 <0.001 
% of alcohol drinker ≥50g/day  990 (1.84) 117 (2.35) 24 (1.99)  95 (7.01) 84 (12.82) 43 (10.70) 0.138 
% of current smokers  161 (0.36) 27 (0.70) 8 (0.89)  6 (2.20) 2  (2.20) 0 (0.00) 0.007 
Data are presented as mean ± SD or No.( %). 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
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Number of Events and Incidence of Stroke according to Blood Pressure 
Level in Respective Proteinuria Status 
 
Table 3 shows the number of events and incidence of stroke according to 
blood pressure level in respective proteinuria status. 
During 11 years of study, the men have had 554 cases of intracerebral 
hemorrhage, 152 cases of subarachnoid hemorrhage, and 1978 cases of ischemic 
stroke. For the women in the same period, there have been 100 cases of 
intracerebral hemorrhage, 67 cases of subarachnoid hemorrhage, and 570 cases 
of ischemic stroke. 
The incidence per 100,000 person-years of intracerebral hemorrhage and 
ischemic stroke increased according to blood pressure level and proteinuria status 
(from the left to the right of the table) in both men and women. The number of 
cases of intracerebral hemorrhage was smaller than ischemic stroke. The 
incidence of intracerebral hemorrhage per 100,000 person-years was greater than 
that of ischemic stroke.
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Table 3. Number of Events and Incidence of Stroke according to Blood Pressure Level in Respective Proteinuria Status 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
No. of events (Incidence per 100000 person-years) 
Total  Proteinuria negative  Proteinuria positive* 
Stroke subtype 
 
 Non- 
Hypertensive 
Stage1  
Hypertension 
Stage2  
Hypertension 
 Non- 
hypertensive 
Stage1  
Hypertension 
Stage2  
hypertension 
Men, N=102,672 N=102,672  N=73,132 N=21,615 N=6,112  N=902 N=564 N=347 
Total Stroke 2,696  (240.9)  1,231  (165.6) 875  (329.6) 478  (636.9)  25  (259.9) 47  (730.6) 40  (1,098.8) 
Intracerebral 
hemorrhage 
554  (49.2)  200  (26.3) 167  (65.0) 143 (225.9)  6  (62.2) 17  (297.1) 21  (731.4) 
Subarachnoid 
hemorrhage 
152  (13.5)  77  (9.7) 53  (21.3) 20  (32.5)  1  (9.9) 1  (8.8) 0  (N/A) 
Ischemic 
stroke 
1,978  (173.4)  938  (127.0) 658 (242.9) 315 (389.8)  18  (185.2) 30  (427.3) 19  (427.3) 
Women, N=60,443 N=60,443  N=53,666 N=4,970 N=1,207  N=454 N=91 N=55 
Total Stroke 749  (113.0)  510  (93.9) 164  (214.3) 64  (487.5)  6 (114.3) 1  (43.8) 4  (471.3) 
Intracerebral 
hemorrhage 
100  (5.2)  55  (10.0) 30  (48.0) 12  (117.7)  2 (34.0) 0  (N/A) 1  (73.8) 
Subarachnoid 
hemorrhage 
67  (3.5)  48  (8.6) 12  (27.3) 7  (39.6)  0 (N/A) 0  (N/A) 0  (N/A) 
Ischemic 
stroke 
570  (27.9)  400  (73.8) 118  (130.4) 43  (325.5)  4 (129.4) 1  (43.8) 4  (471.3) 
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Relative Risks of Stroke according to Blood Pressure Level and 
Proteinuria Status 
 
Table 4 shows relative risks of stroke according to blood pressure level and 
proteinuria status. The multivariate-adjusted relative risks (95 % confidence 
interval) of proteinuria positive were 2.60 (1.71-3.94) for intracerebral 
hemorrhage, 0.44 (0.06-3.21) for subarachnoid hemorrhage, and 1.16 (0.89-1.52) 
for ischemic stroke. The relative risks of stage 1 hypertension were 2.35 (1.82-
3.05) for intracerebral hemorrhage, 1.92 (1.25-2.96) for subarachnoid 
hemorrhage, and 1.29 (1.16-1.44) for ischemic stroke. The relative risks of stage 
2 hypertension were 4.20 (3.15-5.61) for intracerebral hemorrhage, 1.60 (0.98-
2.45) for subarachnoid hemorrhage, and 1.26 (1.10-1.46) for ischemic stroke. 
Proteinuria positive was significantly associated with intracerebral hemorrhage. 
In women, the multivariate-adjusted relative risks of proteinuria positive 
were 2.60 (1.71-3.94) for ischemic stroke, but were not assessable for 
subarachnoid and intracerebral hemorrhage. The relative risks of stage 1 
hypertension were 3.45 (1.80-6.60) for intracerebral hemorrhage, 0.81 (0.30-
2.19) for subarachnoid hemorrhage and 1.09 (0.84-1.42) for ischemic stroke. The 
relative risks of stage 2 hypertension were 3.59 (1.36-9.47) for intracerebral 
hemorrhage, 1.61 (0.46-5.63) for subarachnoid hemorrhage, and 1.22 (0.84-1.78) 
for ischemic stroke. Hypertension was associated with the risk of intracerebral 
hemorrhage, while proteinuria positive was not significantly associated with the 
risk of any stroke subtype. 
 15 
Table 4. Relative Risks of Stroke according to Blood Pressure Level and Proteinuria Status 
RR (95 % CI) † Characteristics 
Total stroke Intracerebral 
hemorrhage 
Subarachnoid 
hemorrhage 
Ischemic stroke 
Men, N=102,672     
No. of cases (Incidence per 100000 person year) 2,696 (241.0) 554 (49.2) 152 (13.5) 1,978 (173.4) 
Blood pressure level     
Non-hypertensive 1.00 1.00 1.00 1.00 
Stage 1 hypertension 1.40 (1.27-1.54) 2.35 (1.82-3.05) 1.92 (1.25-2.96) 1.29 (1.16-1.44) 
Stage 2 hypertension 1.53 (1.35-1.73) 4.20 (3.15-5.61) 1.60 (0.98-2.45) 1.26 (1.10-1.46) 
Proteinuria status     
Negative 1.00 1.00 1.00 1.00 
Positive* 1.35 (1.08-1.70) 2.60 (1.71-3.94) 0.44 (0.06-3.21) 1.16 (0.89-1.52) 
Women, N=60,443     
No. of cases (Incidence per 100000 person year) 749 (113.0) 100 (5.2) 67 (3.5) 570 (27.9) 
Blood pressure level     
Non-hypertensive 1.00 1.00 1.00 1.00 
Stage 1 hypertension 1.25 (0.99-1.58) 3.45 (1.80-6.60) 0.81 (0.30-2.19) 1.09 (0.84-1.42) 
Stage 2 hypertension 1.38 (0.99-1.81) 3.59 (1.36-9.47) 1.61 (0.46-5.63) 1.22 (0.84-1.78) 
Proteinuria status     
Negative 1.00 1.00 1.00 1.00 
Positive* 0.74 (0.30-1.81) N/A N/A 0.90 (0.36-2.20) 
†Adjusted for age, sex, smoking status, amount of alcohol intake, body mass index, blood pressure level, fasting serum glucose, and  
total serum cholesterol levels, and proteinuria. 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
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Relative Risks for Stroke according to Blood Pressure Level in 
Respective Proteinuria Status 
 
Table 5 shows the risks for stroke according to blood pressure level in 
respective proteinuria status. For men in both proteinuria statuses, the non-
hypertensive level of blood pressure was used as a reference category. The risk of 
intracerebral hemorrhage increased as the level of blood pressure went up. The 
amount of increase was greater in men with proteinuria positive than in men with 
proteinuria negative. The risk of subarachnoid hemorrhage and ischemic stroke 
did not increase. The risk of intracerebral hemorrhage increased even after 
additional adjustment for systolic blood pressure as a continuous variable.  
The risks of stroke in women with proteinuria at baseline were not 
assessable because of a small number or absence of events. The significance of 
the risk of intracerebral hemorrhage in women with proteinuria negative changed 
after additional adjustment for systolic blood pressure as a continuous variable.
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Table 5. Relative Risks of Stroke according to Blood Pressure Level in Respective Proteinuria Status 
Intracerebral hemorrhage Subarachnoid hemorrhage Ischemic stroke Proteinuria 
status 
Blood pressure level 
RR (95 % CI)A RR (95 % CI)B RR (95 % CI)A RR (95 % CI)B RR (95 % CI)A RR (95 % CI)B 
Men, N=102,672       
Negative Non-hypertensive 1.00  1.00 1.00  1.00 1.00  1.00 
Negative Stage 1 hypertension 2.19 (1.68-2.86) 1.48 (1.07-2.03) 1.96 (1.27-3.02) 1.53 (0.87-2.68) 1.30 (1.16-1.45) 1.09 (0.95-1.26) 
Negative Stage 2 hypertension 3.92 (2.91-5.29) 1.54 (0.90-2.65) 1.70 (0.91-3.17) 0.96 (0.33-2.75) 1.27 (1.10-1.47) 0.86 (0.66-1.11) 
Positive* Non-hypertensive 1.00  1.00 1.00  1.00 1.00  1.00 
Positive* Stage 1 hypertension 18.77 (2.40-146.95) 22.74 (2.62-197.67) N/A N/A 1.00 (0.51-1.98) 0.73 (0.32-1.64) 
Positive* Stage 2 hypertension 30.48 (3.85-241.71) 45.03 (3.85-526.41) N/A N/A 0.79 (0.36-1.71) 0.39 (0.11-1.40) 
Women, N=60,443       
Negative Non-hypertensive 1.00  1.00 1.00  1.00 1.00  1.00 
Negative Stage 1 hypertension 3.45 (1.80-6.60) 2.11 (0.86-5.20) 0.81 (0.30-2.19) 0.35 (0.10-1.16) 1.11 (0.85-1.44) 1.11 (0.79-1.57) 
Negative Stage 2 hypertension 3.59 (1.36-9.47) 1.41 (0.30-6.66) 1.61 (0.46-5.63) 0.29 (0.04-2.02) 1.25 (0.86-1.83) 1.27 (0.73-2.21) 
Positive* Non-hypertensive 1.00  1.00 1.00  1.00 1.00  1.00 
Positive* Stage 1 hypertension N/A N/A N/A N/A N/A N/A 
Positive* Stage 2 hypertension N/A N/A N/A N/A N/A N/A 
A: Adjusted for age, sex, smoking status, amount of alcohol intake, body mass index, fasting serum glucose, and total serum cholesterol levels. 
B: Adjusted for variables mentioned in A and systolic blood pressure as a continuous variable. 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
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Receiver Operating Characteristic (ROC) Analysis of Systolic 
Blood Pressure for Identification of Men at Risk of Intracerebral 
Hemorrhage in Respective Proteinuria Status 
 
Table 6 shows the result of receiver operating characteristic (ROC) analysis 
of systolic blood pressure for identification of men at risk of intracerebral 
hemorrhage in respective proteinuria status. The systolic blood pressure with 
largest area under curve (AUC) value was 140 mmHg in men with proteinuria 
negative and 135mmHg in men with proteinuria positive. In systolic blood 
pressure 135mmHg, the difference between the AUC values in respective 
proteinuria status was statistically significant.
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Table 6. Results of Receiver Operating Characteristic (ROC) Analysis of Systolic Blood Pressure for  
Identification of Men at Risk of Intracerebral Hemorrhage in Respective Proteinuria Status 
Proteinuria negative  Proteinuria positive*  Systolic blood 
pressure, mmHg 
 
Sensitivity Specificity AUC†  Sensitivity Specificity AUC†  
P-value 
95  1.00 0.00 0.647  1.00 0.00 0.646  0.942 
100  1.00 0.00 0.648  1.00 0.01 0.648  0.942 
105  0.99 0.05 0.653  1.00 0.03 0.650  0.942 
110  0.98 0.12 0.661  1.00 0.07 0.649  0.965 
115  0.93 0.26 0.670  0.98 0.14 0.676  0.661 
120  0.86 0.42 0.681  0.98 0.24 0.715  0.254 
125  0.78 0.59 0.714  0.92 0.36 0.723  0.482 
130  0.68 0.71 0.728  0.89 0.49 0.770  0.067 
135  0.56 0.81 0.731  0.85 0.60 0.789  0.045 
140  0.47 0.88 0.732  0.75 0.69 0.785  0.207 
145  0.33 0.92 0.711  0.57 0.78 0.746  0.375 
150  0.26 0.95 0.708  0.40 0.83 0.707  0.832 
† AUC: Area under curve, adjusted for age, sex, smoking status, amount of alcohol intake, body mass index, fasting serum  
glucose, and total serum cholesterol levels. 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
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5. DISCUSSION 
 
The main results of this study show that the risk of intracerebral hemorrhage 
in hypertensive men with proteinuria positive greatly increased compared to the 
men with proteinuria negative. The risk of ischemic stroke or subarachnoid 
hemorrhage in men with proteinuria positive did not increase significantly. 
 
Blood Pressure, Proteinuria and Risk of Stroke 
 
This study show that the risk of intracerebral hemorrhage in hypertensive 
men with proteinuria positive increased greatly. As it is expected, hypertension 
was prevalent in subjects with proteinuria positive. Calculated from Table 3, 
men with proteinuria positive had a 50.2 % prevalence of hypertension, whereas 
only 27.5 % of men with proteinuria negative had hypertension. For women, 
24.3 % with proteinuria positive had hypertension and only 10.3 % of women 
that had proteinuria negative had hypertension. The risk assessment based on 
blood pressure level and proteinuria status seems appropriate to implement 
preventive interventions, which could emphasize the early screening and 
intensive control of hypertension and proteinuria, using such drugs as 
angiotensin converting enzyme (ACE) inhibitors or angiotensin antagonist. 
These drugs are known effective for blood pressure control and proteinuria 
reduction. (Ibrahim et al, 2006; Consentino et al, 2001) 
The significant association between proteinuria, hypertension and 
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intracerebral hemorrhage in women was not observed in this study. Some 
previous studies mentioned lower or insignificant risk of proteinuria for the risk 
of stroke in women. (Jee et al, 2005; Tsioufis et al, 2004; Roest et al, 2001) This 
result could be due to the small number of women profiled and the relatively 
healthier risk factor profiles of women. (Table 1, 4) 
In this population study, the blood pressure categories were used to describe 
the impact of high blood pressure on the risk of stroke in men with proteinuria 
positive. To evaluate the predictability of intracerebral hemorrhage in specific 
blood pressure levels in respective proteinuria status, receiver operating 
characteristic (ROC) analysis was performed for men. The results of ROC 
analysis showed that systolic blood pressure level 135mmHg in men with 
proteinuria positive is highest in predicting intracerebral hemorrhage during 11 
years. (Table 6) Considering the upward shift of systolic blood pressure in men 
with proteinuria positive,(Table 2) it could be suggested that lower value (under 
135mmHg) of systolic blood pressure in men with proteinuria positive, as a cut-
off level in order to detect subjects at risk of intracerebral hemorrhage. In further 
analysis, cut-point of the JNC-7 report, targeting baseline blood pressure levels as 
130/80mmHg in people with diabetes or chronic kidney disease was used. For 
men with proteinuria positive, there were 43 out of 44 events of intracerebral 
hemorrhage in men with baseline blood pressure levels above 130/80 mmHg. 
(Appendix table 1) When the cut-point was changed into baseline blood pressure 
level 120/80 mmHg (Normal category of JNC-7 classification), there were all (44 
out of 44) events of intracerebral hemorrhage in men with baseline blood 
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pressure level above 120/80 mmHg in men with proteinuria positive. (Appendix 
table 2) Thus, it could be concluded that the result from this study strongly 
support JNC-7 recommendation targeting blood pressure level as 130/80 mmHg, 
in men with proteinuria positive. 
 
Possible Explanations 
 
A simple multiplication of relative risks from Table 4 for intracerebral 
hemorrhage in men with proteinuria positive and stage 1 hypertension is 6.11, yet 
in this study, it was found that relative risk of intracerebral hemorrhage for men 
with the same conditions to be 18.77. The gap increased greater for people with 
proteinuria positive and stage 2 hypertension (10.9 to 30.5). Thus, the risk is not 
merely explained by a simple additive or multiplicative effect of two risk factors. 
Explanation on a synergistic effect of hypertension and proteinuria on the risk of 
intracerebral hemorrhage can be proposed. 
First, endothelial dysfunction might aggravate the risk of intracerebral 
hemorrhage in hypertensive subjects. Intracerebral hemorrhage is known as the 
most sensitive stroke subtype to hypertension. (Cosentino et al, 2005; Song et al, 
2004) In men with hypertension, proteinuria might play a role in increasing risk 
of intracerebral hemorrhage in this study. Proteinuria is caused by increased 
permeability of an injured endothelium. An injured endothelium results in 
increased adhesiveness, decreased nitric oxide release, altered production of 
vaso-active mediators, and most importantly, atherosclerosis. (Tsioufis et al, 
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2004; Paisley et al, 2003; Consentino et al, 2001) These findings point out that 
proteinuria could be a marker of early intravascular destruction. (Paisley et al, 
2003) An injured endothelium does not respond to elevated blood pressure or 
anti-hypertensive, which could lead to cardiovascular accidents. (Ibrahim et al, 
2006; Consentino et al, 2001; Samuelsson et al, 1985) Thus, it could be 
summarized that the interaction between higher blood pressure level and an 
injured endothelium might lead to intracerebral hemorrhage. 
Second, the increased risk of intracerebral hemorrhage, rather than ischemic 
stroke or subarachnoid hemorrhage, might be due to increased hemorrhagic 
tendency in men with protineuria. In previous studies that reported on the 
positive association between proteinuria and stroke, most of the research on 
ischemic stroke did not include intracerebral hemorrhage, which was not 
prevalent in western countries. Studies in Japan reported stronger association 
between proteinuria and ischemic stroke than intracerebral hemorrhage, which 
was quite different from the results of this study. As mentioned above, the result 
of this study was partly explained by a strong association between intracerebral 
hemorrhage and high blood pressure levels. In this study, the risk of intracerebral 
hemorrhage in men with proteinuria positive was higher even after the additional 
adjustment for blood pressure level, whereas, the risks of subarachnoid 
hemorrhage and ischemic stroke were not significantly increased in men with 
both hypertension and proteinuria positive. Increased hemorrhagic tendency in 
people with proteinuria has been reported. In some studies, proteinuria is known 
to represent the duration and severity of hypertension, with underlying arterial 
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remodeling and loss of distensibility. Arterial remodeling could lead to the 
rupture and hemorrhage of blood vessels. (Stennett et al, 2006;; Lin et al, 1984) 
ACE inhibitors, which are known to prevent arterial remodeling, is reported to 
cause both endothelium recovery and proteinuria reduction in some studies. 
Some common mechanisms related to proteinuria and vascular remodeling was 
suggested. (Rossi et al, 1995) The close association between proteinuria and 
hemorrhagic stroke has been recognized in many case reports of hemorrhagic 
stroke in preeclampsia. In preeclampsia, vascular reactivity and activation of 
coagulation cascade, which lead to cerebral hemorrhage. (Granger et al, 2001; 
Pridjian et al, 2002; Stennett et al, 2006) Thus, it could be summarized that 
increased hemorrhagic tendency in proteinuria might lead to intracerebral 
hemorrhage. 
The smaller risk of ischemic stroke may be due to a relatively younger age 
distribution of this study population. Ischemic stroke is largely from carotid 
artery atherosclerosis and thrombus from cardiac origin. From previous studies, 
atherosclerosis progressed with age and the risk significantly increased in men 
aged 45 years and older and in women aged 55 years and older. (Kasper et al, 
2005) In this study the mean age was 44.92 years for men and 42.42 for women. 
(Table 1) Further analysis was performed on the risk of ischemic stroke 
according to blood pressure level in different age groups. The risk of ischemic 
stroke in men aged 45 years and older was not significantly higher than in men 
aged less than 45 years. (Appendix table 3) 
Third, there is a possibility of confounding variables of blood pressure, 
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which was categorized as 3 categorical variables. However, systolic blood 
pressure as a continuous variable was adjusted and the risk did not change 
significantly after adjustment. 
 
Strengths and Limitations 
 
This study has several important strengths. First, this study had a large 
sample size (102,672 men and 60,443 women) and a long follow-up period (11 
years). Most previous studies on stroke investigated ischemic stroke or had a 
short follow-up period. This study included enough sample sizes and follow-up 
period for investigating stroke in various subtypes. Second, there were repeatedly 
measured major independent variables over 2 years; thus, the possibility of 
measurement errors could be decreased. Third, in this study, proteinuria positive 
was defined as a dipstick finding of 1+ or greater in both the 1990 and 1992 
examination. These methods could improve the sensitivity of detecting 
proteinuria with high specificity, since measuring dipstick proteinuria is known 
to have low sensitivity and high specificity. (Atkins et al, 2003; Pugia et al, 
2001) For all our efforts, the prevalence of proteinuria positive in hypertensive 
subjects (3.18 % in men and 2.38 % in women) was low compared to previous 
reports. These findings could alleviate the strength of association in this study. 
This study has potential limitations. First, the diagnosis from hospitalization 
and death certificate data was not verified. Thus, there is some possibility of 
inaccurate diagnosis and a misclassification bias. However, a misclassification 
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bias, if any, would likely to cause a reduction of relative risk since the 
misclassification would mainly be due to unclassified events rather than 
misdiagnosis. According to Korean nationwide survey data, the use of 
computerized tomography for stroke was 89 % in 1999 and 2000. Second, with 
dilute urine specimens, significant proteinuria could be overlooked with dipstick 
methods because a trace reading from a dipstick method is known to indicate a 
protein concentration of 1 to 30mg/100mL. (Atkins et al, 2003) This level has 
been reported to be associated with cardiovascular mortality. Thus, 
misclassification bias, if any, would likely cause a reduction of the relative risk. 
Third, although adjustment was performed for as many confounding variables as 
possible, residual confounding might still exist. 
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6. CONCLUSION 
 
In Korean men with hypertension, the risk for intracerebral hemorrhage 
significantly increased when proteinuria was detected. This finding was not 
observed in women. Therefore, it could be concluded that the early screening and 
aggressive management of both hypertension and proteinuria is important to 
prevent intracerebral hemorrhage in men.  
For early detection and management for people at the risk of intracerebral 
hemorrhage, health examination using the dipstick method could be emphasized. 
Intracerebral hemorrhage is prevalent in developing countries. In these countries, 
detecting proteinuria with the dipstick method and blood pressure measurement 
could be a cheap and easy way of detecting the at-risk population for 
intracerebral hemorrhage before using UAER on a specific population thought to 
have a certain disease. 
From the results of this study, it could be suggested that people detected 
with proteinuria, the blood pressure should be checked and controlled under a 
level at least 135mmHg and hopefully under 130mmHg. Further medical 
evaluation on the cause of proteinuria (ex,nephritic syndrome, glomerulonephritis, 
impaired fasting glucose, diabetes) should be performed. According to the cause 
of proteinuria, appropriate management of both proteinuria and blood pressure 
should be performed. 
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Appendix table 1. Number of Stroke Events according to Blood Pressure Level in Respective  
Proteinuria Status in Men 
Number of stroke events Proteinuria 
status 
Systolic blood    Diastolic blood 
pressure, mmHg  pressure, mmHg Intracerebral 
hemorrhage 
Subarachnoid 
hemorrhage 
Ischemic 
stroke 
Negative <130 And     80 65 21 314 
Negative 130-139 or 80-89 135 56 624 
Negative 140-159 or 90-99 167 53 658 
Negative ≥160 or ≥100 143 20 315 
Positive* <130 and <80 1 1 6 
Positive* 130-139 or 80-89 5 0 12 
Positive* 140-159 or 90-99 17 1 30 
Positive* ≥160 or ≥100 21 0 19 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination. 
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Appendix table 2. Number of Stroke Events by Subtype according to JNC-7 Classification  
of Blood Pressure Level in Respective Proteinuria status in Men 
Number of stroke events Proteinuria 
status 
Blood pressure level 
according to  
JNC-7 classification 
Intracerebral 
hemorrhage 
Subarachnoid 
hemorrhage 
Ischemic 
stroke 
Negative Normal 45 17 234 
Negative Pre-hypertension 155 60 704 
Negative Stage 1 hypertension 167 53 658 
Negative Stage 2 hypertension 143 20 315 
Positive* Normal 0 1 3 
Positive* Pre-hypertension 6 0 15 
Positive* Stage 1 hypertension 17 1 30 
Positive* Stage 2 hypertension 21 0 19 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
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Appendix table 3. Relative Risks of Ischemic Stroke according to Blood Pressure  
Level in Respective Proteinuria Status in Men 
RR (95 %CI) of ischemic stroke Proteinuria 
status 
Blood pressure level 
Age<45 years Age≥45 years 
Negative Non-hypertensive 1.00 1.00  
Negative Stage 1 hypertension 1.51 (1.21-1.87) 1.27 (1.12-1.44) 
Negative Stage 2 hypertension 1.42 (1.01-1.99) 1.29 (1.10-1.51) 
Positive* Non-hypertensive 1.00 1.00  
Positive* Stage 1 hypertension 0.24 (0.02-3.20) 0.91 (0.41-2.03) 
Positive* Stage 2 hypertension N/A 0.65 (0.28-1.74) 
* Defined as at least 1+ or greater of dipstick finding in 1990 and 1992 examination.
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Abstract in Korean 
 
단백뇨 검출여부에 따른 
혈압수준과 뇌졸중 위험의 연관성 
 
연세대학교 대학원 보건학과 
하경수 
 
고혈압은 뇌졸중의 가장 중요한 위험 인자로 알려져 있다. 그 연
관성에 관한 많은 연구가 있었으나, 단백뇨가 검출된 성인에서의 고혈
압과 뇌졸중의 위험에 대해서는 연구가 부족하다. 추적 연구를 통해 
단백뇨 검출여부에 따라 고혈압이 뇌출혈에 미치는 영향을 알아보았다. 
본 연구는 Korea Medical Insurance Corporation (KMIC) 코호
트 자료를 이용하였다. 연구대상은 1990년과 1992년 두 차례의 건강 
검진에 모두 참여한 35-59세의 남 102,672 명, 녀 60,443 명 이었
다. 단백뇨 양성은 90년과 92년의 두 차례의 dipstick 검사상 한 번 
이상의 결과가 1+ 이상으로 나온 것으로, 혈압 수준은 JNC-7 기준을 
이용하여 비고혈압, 고혈압 제 1기, 제 2기로 구분하였다. 종속변수는 
1993년부터 2004년의 추적관찰기간 동안 발생한 뇌출혈, 지주막하 
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출혈, 허혈성 뇌졸중으로 하였다. 뇌졸중 발생 위험 분석 위해 Cox의 
비례위험 모델을 이용하여 검진 시 연령, 체질량 지수, 혈당농도, 콜레
스테롤 농도, 흡연력, 음주량 등을 보정하고 상대위험도를 계산하였다. 
남성에서 11년 동안 554 건의 뇌출혈, 152 건의 지주막하출혈, 
1978 건의 허혈성 뇌졸중이 발생했다. 단백뇨의 상대위험도는 뇌출혈 
2.60 (1.71-3.94), 지주막하출혈 0.44 (0.06-3.21), 허혈성 뇌졸중 
1.16 (0.89-1.52) 이었다. 제2기 고혈압의 상대위험도는 뇌출혈 
4.20 (3.15-5.61), 지주막하출혈 1.60 (0.98-2.45), 허혈성 뇌졸중 
1.26 (1.10-1.46) 이었다. 단백뇨 미 검출 남성보다 단백뇨 검출 남
성에서 혈압수준이 올라갈수록 뇌출혈 위험의 증가 폭이 현저 하였다. 
이와 같은 결과는 다른 종류의 뇌졸중이나 여성에서는 발견할 수 없었
다.  단백뇨 검출여부에 따라, 혈압 수준에 따른 뇌출혈 예측력 파악을 
위한 ROC 분석에서 단백뇨가 검출된 남성에서 수축기 혈압 기준을 
`135mmHg로 할 때 뇌출혈 위험 예측력이 가장 큰 것으로 나타났다. 
요약하면, 이 연구는, 단백뇨 검출 시, 남성에서 고혈압으로 인한 
뇌출혈의 위험이 단백뇨 미 검출 시 보다 현저하게 증가하며, 뇌출혈 
예방을 위한 적정 수준의 혈압조절과 아울러 단백뇨의 조기 발견과 조
절이 큰 도움이 될 수 있음을 보여주었다. 
____________________________________________________________ 
핵심되는 말: 단백뇨, 고혈압, 뇌출혈 
